Join this webinar to learn more about the pivotal role of noninvasive tests, including VCTE™, for earlier identification and risk stratification of at-risk patients.
Dr. Mazen Noureddin and Dr. Naim Alkhouri will review and discuss the patient clinical care pathways now recommended by the main Gastroenterology and Diabetology guidelines (including AASLD, EASL, AGA and AACE) and how to optimize patient management as NASH-dedicated therapies are on the horizon.